JCAR015 Experience Informs Future CAR-T Studies – OncLive – OncLive
OncLive |
JCAR015 Experience Informs Future CAR-T Studies – OncLive
OncLive The high rates of cerebral edema seen with JCAR015 in the phase II ROCKET trial were attributed to early and rapid chimeric antigen receptor (CAR)-modified … Juno analysis of shuttered study offers clues for CAR-T | BioPharma … Juno Dissects ROCKET Deaths, Will Aim Better CAR-T at Leukemia … |
